This week’s newsletter covers promising findings on THC/CBD for dementia care, questions about CBD product labeling accuracy, drug interactions to be aware of during chemotherapy, and a wide-ranging psychedelics research round-up touching on personality change, […]
This week’s newsletter covers MDMA’s potential effects on memory, safety concerns around ibogaine, ethical questions in the psychedelic investment space, new research on CBD and liver health, prenatal cannabis exposure findings, cannabis for migraine relief, […]
This week’s newsletter covers a major analysis exposing synthetic cannabinoids in online hemp products, plus a research round-up on CBD’s potential against melanoma, cannabis roots’ cancer-fighting properties, CBD’s role in neuronal repair, and cannabinoids as […]
This week’s newsletter covers new survey data on CBD use in America, environmental concerns around illicit cannabis cultivation, the impact of flawed drug testing on new mothers, and the latest research on cannabinoids and cardiac […]
This week’s newsletter covers groundbreaking research on ayahuasca’s effects on PTSD-related brain circuits, CBD’s potential for traumatic brain injury recovery, the endocannabinoid system’s role in exercise-induced depression protection, ibogaine’s neurorestorative properties, and the nutritional promise […]
This week’s plant medicine newsletter covers consumer trends in CBD use as a pharmaceutical substitute, the science of cannabinoids and alcohol, THC’s limitations as a driving impairment marker, and new research on cannabinoids in liver […]
This week’s newsletter covers research on cannabinoids and brain aging, a roundup of new CBD studies spanning sleep, arthritis, skin protection, and cancer, and emerging findings on cannabis as a supportive therapy for Parkinson’s patients. […]
This week’s newsletter explores the political roots of psychedelic prohibition, ancient uses of mind-altering substances, new research on how psilocybin and DMT affect the brain, and emerging questions about what really makes magic mushrooms psychoactive. […]
This week’s newsletter covers Delta-8 THC labeling and dosage concerns, the rise of mushroom-infused products in retail settings, the ongoing impact of decades-old cannabis convictions, and new research linking psychedelic use to enhanced cognitive flexibility. […]
This week’s newsletter covers whole-plant cannabis extracts versus isolated THC for chronic pain, the intersection of mental health and cannabis use, the politics of marijuana criminalization, and new perspectives on how psychedelics affect the mind. […]
© Copyright 2018-2026 HempEtCetera.com, Hemp Et Cetera™ is a unit of SoCal Broadband Inc. All rights reserved.